MediXall Group, Inc. - FORM 10-K - EX-32.1 - CERTIFICATION PURSUANT TO 18 U.S.C. 1350 - June 17, 2021

Attached files

file filename
EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 - MediXall Group, Inc.mdxl_ex31z1.htm
10-K - ANNUAL REPORT - MediXall Group, Inc.mdxl_10k.htm
EX-32.2 - CERTIFICATION - MediXall Group, Inc.mdxl_ex32z2.htm
EX-31.2 - CERTIFICATION PURSUANT TO RULE 13A-14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 - MediXall Group, Inc.mdxl_ex31z2.htm

 

EXHIBIT 32.1

 

CERTIFICATION

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the annual report of MediXall Group, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Neil Swartz, Interim Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
   
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: June 17, 2021 /s/ Neil Swartz
  Neil Swartz
  Interim Chief Executive Officer
  (Principal Executive Officer)

 

 

MediXall Group, Inc. Reports